http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011124905-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L29-10 |
| filingDate | 2009-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2011124905-A |
| titleOfInvention | ANTIOXIDANT |
| abstract | 1. A drug for inhibiting the formation of lipid peroxide, containing a compound selected from a derivative of cyclolanostane and a derivative of lophenol, as an active ingredient. The drug according to claim 1, containing a cyclolanostane derivative and a lophenol derivative in the following weight ratio: cyclolanostane derivative: lophenol derivative = 6.3: 2.7-5.1: 4.9.3. The medicament according to claim 1, comprising a compound selected from a cyclolanostane derivative and a lophenol derivative, at a concentration of at least 0.0001 wt.%. The medicament according to claim 1, wherein the cyclolanostane derivative is selected from 9.19-cyclolanostan-3-ol and 24-methylene-9.19-cyclolanostan-3-ol. The medicament according to claim 1, wherein the lophenol derivative is selected from 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol, and 4-methylstigmast-7-en-3-ol. A method for manufacturing a medicament according to any one of claims 1 to 5, comprising mixing a compound selected from a cyclolanostane derivative and a lophenol derivative as an active ingredient. A food product or drink for inhibiting the formation of lipid peroxide containing a compound selected from a cyclolanostane derivative and a lophenol derivative as an active ingredient. 8. The food product or drink according to claim 7, containing a cyclolanostane derivative and a lophenol derivative in the following weight ratio: cyclolanostane derivative: lophenol derivative = 6.3: 2.7-5.1: 4.9.9. The food product or drink according to claim 7, containing a compound selected from a cyclolanostane derivative and a lophenol derivative, at a concentration of at least 0.0001 wt.%. The food product or drink according to claim 7, where |
| priorityDate | 2008-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.